Business ❯Pharmaceuticals

Manufacturing

Investment Job Creation Labor Relations Safety Regulations Production Sites Product Control Production Issues Supply Chain Domestic Production Trade Policies Tariffs Environmental Issues RayzeBio Inc Investments Drug Production

Novartis Confirms $23 Billion U.S. Investment with Major Expansion Plans

Novartis Announces $23 Billion U.S. Expansion with New Plants and R&D Hub

Sanofi Employees Protest Planned Sale of Amilly Factory

Sanofi Indicted Over Toxic Emissions at Mourenx Plant

Pfizer Considers Relocating Overseas Manufacturing to U.S. Facilities

Eli Lilly Announces $27 Billion Investment in U.S. Manufacturing Expansion

Eli Lilly Announces $3 Billion Wisconsin Manufacturing Expansion

French Government Seeks Job Guarantees in Sanofi's Doliprane Sale

Eli Lilly Invests $1.8 Billion to Expand Drug Production in Ireland

Eli Lilly Invests $9 Billion to Boost Production of Weight Loss Drugs

Bristol Myers Squibb Acquires RayzeBio for $4.1 Billion